CARING AMBASSADORS

Empowering People to be Ambassadors of their Own Health Since 1997.

HEPATITIS C PROGRAM


Monthly Pubmed Review

Monthly Pubmed Review of the Most Relevant Research on Hepatitis C
Literature Review, November 2014

CLINICAL TRIALS, COHORT STUDIES, PILOT STUDIES

BASIC AND APPLIED SCIENCE, PRE-CLINICAL STUDIES

HIV/HCV COINFECTION

COMPLEMENTARY AND ALTERNATIVE MEDICINE

EPIDEMIOLOGY, DIAGNOSTICS, AND MISCELLANEOUS WORKS

Provision of Clinical Pharmacist Services for Individuals With Chronic Hepatitis C Viral Infection: Joint Opinion of the GI/Liver/Nutrition and Infectious Diseases Practice and Research Networks of the American College of Clinical Pharmacy.

A system for the continuous directed evolution of proteases rapidly reveals drug-resistance mutations.

An Extensive Antigenic Footprint Underpins Immunodominant TCR Adaptability against a Hypervariable Viral Determinant.

The continuum of hepatitis C testing and care.

COBAS® AmpliPrep/COBAS® Taqman ® HCV Quantitative Test, Version 2.0: An In Vitro Test for Hepatitis C Virus RNA Quantification.

Functional conservation despite structural divergence in ligand-responsive RNA switches.

Persistent HCV infection impairs ribavirin antiviral activity through clathrin-mediated trafficking of equilibrative nucleoside transporter 1.

A View of the E2-CD81 Interface at the Binding Site of a Neutralizing Antibody against Hepatitis C Virus.

Sofosbuvir-based treatment regimens for chronic, genotype 1 hepatitis C virus infection in u.s. Incarcerated populations: a cost-effectiveness analysis.

Coding algorithms for identifying patients with cirrhosis and hepatitis B or C virus using administrative data.

Hepatitis C Diagnostics: Clinical Evaluation of the HCV-Core Antigen Determination.

The characteristics of rare codon clusters in the genome and proteins of hepatitis C virus; a bioinformatics look.

Relative effects of heavy alcohol use and Hepatitis C in decompensated chronic liver disease in a hospital inpatient population.

Screening, Diagnosis, Treatment, and Management of Hepatitis C: A Novel, Comprehensive, Online Resource Center for Primary Care Providers and Specialists.

Mass Balance, Metabolite Profile and in vitro-in vivo Comparison of Clearance Pathways of Deleobuvir, a Hepatitis C Polymerase Inhibitor.

Cost-effectiveness of rapid HCV testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs.

Vitamin D pathway gene variants and HCV-2/3 therapy outcomes.

LIVER CANCER

Caring Ambassadors Program, Inc. | P.O. Box 1748 | Oregon City, OR 97045 | 503-632-9032 | 503-632-9038 (Fax)